h f feed angle (deg) x rotation rate (deg h -1 ) l viscosity of the solvent, kg m -1 s -1 l H n n th normalized moment l n n th moment about the mean 1.1
Lipases and Phospholipases in Drug Development (From Biochemistry to Molecular Pharmacology) || Phospholipase D
✍ Scribed by Müller, Günter; Petry, Stefan
- Publisher
- Wiley-VCH Verlag GmbH & Co. KGaA
- Year
- 2005
- Tongue
- German
- Weight
- 289 KB
- Edition
- 1
- Category
- Article
- ISBN
- 3527306773
No coin nor oath required. For personal study only.
✦ Synopsis
His and Lys residues contributed by the two HKD motifs.
📜 SIMILAR VOLUMES
Lipases And Phospholipases Are Key Control Elements In Mammalian Metabolism. They Share Many Common Features That Set Them Apart From Other Metabolic Enzyme Classes, Most Importantly Their Association With Biological Membranes. Their Potential As Drug Targets For The Treatment Of Metabolic Diseases
Lipases And Phospholipases Are Key Control Elements In Mammalian Metabolism. They Share Many Common Features That Set Them Apart From Other Metabolic Enzyme Classes, Most Importantly Their Association With Biological Membranes. Their Potential As Drug Targets For The Treatment Of Metabolic Diseases
Lipases And Phospholipases Are Key Control Elements In Mammalian Metabolism. They Share Many Common Features That Set Them Apart From Other Metabolic Enzyme Classes, Most Importantly Their Association With Biological Membranes. Their Potential As Drug Targets For The Treatment Of Metabolic Diseases
Lipases And Phospholipases Are Key Control Elements In Mammalian Metabolism. They Share Many Common Features That Set Them Apart From Other Metabolic Enzyme Classes, Most Importantly Their Association With Biological Membranes. Their Potential As Drug Targets For The Treatment Of Metabolic Diseases
Lipases And Phospholipases Are Key Control Elements In Mammalian Metabolism. They Share Many Common Features That Set Them Apart From Other Metabolic Enzyme Classes, Most Importantly Their Association With Biological Membranes. Their Potential As Drug Targets For The Treatment Of Metabolic Diseases